Technology & Products

Pluristem PluriX™ 3D Bioreactor

Pluristems PLacental eXpanded

(PLX) Cells

PLX-PAD for Peripheral Artery Disease

PLX-IBD for Inflammatory Bowel Disease
PLX-MS for Multiple Sclerosis
PLX-STROKE for Ischemic Stroke

PLX-BMT as an Alternative to BMT

FAQs
List of publications
Glossary

List of Publications

Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats
Brain Research 1315 (2010) 128–136
12 January 2010

 

The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of
critical limb ischemia

ISCT, informa healthcare
Cytotherapy (2009) Vol. 00, No. 1-8
12 June 2009

 

Safety and Biodistribution Profie of Placental-derived Mesenchymal Stromal Cells
(PLX-PAD) Following Intramuscular Delivery

Toxicologic Pathology, 000: 1-11, 2009
28 May 2009

 

Cytokines as the Major Mechanism of MSC Clinical Activity:
Expanding the Spectrum of Cell Therapy

Israel Medical Association World Federation Conference
IMAj, Vol. 11
April 2009

 

Pluristem Therapeutics Inc. - Company Profile
Regenerative Medicine, (2008) 3(1), 117-122
January 2008

 
Home   |   The Company   |   Technology   |   Investor Relations   |   Press Room   |   Privacy policy   |   Contact Us
Copyright © 2008 Pluristem Therapeutics Inc. All rights reserved Design by Mootag